<code id='27DD6A672E'></code><style id='27DD6A672E'></style>
    • <acronym id='27DD6A672E'></acronym>
      <center id='27DD6A672E'><center id='27DD6A672E'><tfoot id='27DD6A672E'></tfoot></center><abbr id='27DD6A672E'><dir id='27DD6A672E'><tfoot id='27DD6A672E'></tfoot><noframes id='27DD6A672E'>

    • <optgroup id='27DD6A672E'><strike id='27DD6A672E'><sup id='27DD6A672E'></sup></strike><code id='27DD6A672E'></code></optgroup>
        1. <b id='27DD6A672E'><label id='27DD6A672E'><select id='27DD6A672E'><dt id='27DD6A672E'><span id='27DD6A672E'></span></dt></select></label></b><u id='27DD6A672E'></u>
          <i id='27DD6A672E'><strike id='27DD6A672E'><tt id='27DD6A672E'><pre id='27DD6A672E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:65329
          glum Benjamin — health insurance coverage from STAT
          Adobe

          Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public within the past two years. All three used their stage time at the J.P. Morgan Healthcare Conference to make the case that their drastic decisions — like fully exiting some insurance markets — will deliver the profitability investors are demanding.

          “Insurance company profitability is the number one goal,” Oscar CEO Mario Schlosser said in an interview with STAT in San Francisco.

          advertisement

          “We are actually absolutely focused on profitability right now,” Clover CEO Andrew Toy said during his presentation on Wednesday.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          First U.S. drug developed to treat liver disease MASH is approved
          First U.S. drug developed to treat liver disease MASH is approved

          AdobeTheFoodandDrugAdministrationonThursdayapprovedthefirstmedicinedevelopedspecificallytotreatthese

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          How many hemophilia patients actually want gene therapy?

          AdobeAsaboygrowingupwithhemophiliaA,NoahFrederickreservedtheendofhisannualcheckupstotalkaboutnewtech